Back to search
Subarachnoid Hemorrhage of Aneurysmal Cause
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Subarachnoid Hemorrhage of Aneurysmal Cause trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Subarachnoid Hemorrhage of Aneurysmal Cause trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate if clazosentan (on top of normal routine medical care) can reduce the risk of developing complications related to cerebral vasospasm an…
The aim of this study is to demonstrate that clazosentan, administered as a continuous intravenous infusion at 5 mg/h until Day 14 post aneurysmal subarachnoid…